Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker

Prostate cancer is responsible for hundreds of thousands of annual deaths worldwide. The current gold standard in early detection of prostate cancer, the prostate specific antigen test, boasts a high sensitivity but low specificity, resulting in many unnecessary prostate biopsies. Thus, emphasis has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Levin, Rachel A., Lund, Maria E., Truong, Quach, Wu, Angela, Shore, Neal D., Saltzstein, Daniel R., Concepcion, Raoul S., Paivanas, Thomas A., van Breda, Arletta, Beebe-Dimmer, Jennifer, Ruterbusch, Julie J., Wissmueller, Sandra, Campbell, Douglas H., Walsh, Bradley J.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5976470/
https://ncbi.nlm.nih.gov/pubmed/29854284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados